Caffeine Anhydrous

Hazard statements (CLP)

H302

Code

Statements

H302

Harmful if swallowed

SECTION 2: Hazards identification

Regulation, UK SI 2019/720, and UK SI 2020/1567 Classification of the substance or mixture Classified according to GB-CLP Regulation, UK SI 2019/720 and UK SI H302 - Acute Toxicity (Oral) Category 4 2020/1567 1] Legend Classified by Chemwatch; 2. Classification drawn from GB-CLP Regulation, UK SI 2019/720 and UK SI 2020/1567

Signal word

Warning

Hazard statements

H302 Harmful if swallowed.

Supplemental label elements

Not Applicable

Prevention

P264 Wash all exposed external body areas thoroughly after handling. P270 Do not eat, drink or smoke when using this product.

Response

P301+P312 IF SWALLOWED: Call a POISON CENTER/doctor/physician/first aider if you feel unwell. P330 Rinse mouth.

Storage

Not Applicable

Disposal

P501 Dispose of contents/container to authorised hazardous or special waste collection point in accordance with any local regulation. Material contains caffeine.

2.3 Other hazards

REACH - Art.57-59: The mixture does not contain Substances of Very High Concern (SVHC) at the SDS print date. This substance/mixture does not meet the criteria for classification as Persistent, Bioaccumulative, and Toxic (PBT) in accordance with Annex XIII, Commission Delegated Regulation (EU) 2017/2100, and Commission Regulation (EU) 2018/605. This substance/mixture does not meet the criteria for classification as very Persistent and very Bioaccumulative (vPvB) in accordance with Annex XIII, Commission Delegated Regulation (EU) 2017/2100, and Commission Regulation (EU) 2018/605. This substance/mixture does not meet the criteria for classification as Persistent, Mobile and Toxic (PMT) in accordance with Commission Delegated Regulation (EU) 2023/707. This substance/mixture does not meet the criteria for classification as very Persistent and very Mobile (vPvM) in accordance with Commission Delegated Regulation (EU) 2023/707. The substance/mixture does not contain components considered to have endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605, nor is it included in the list established under REACH Article 59(1), at concentrations equal to or greater than 0.1% (w/w). No further product hazard information.

2.1 Classification of the substance or mixture

Classified according to GB-CLP Regulation, UK SI 2019/720 and UK SI H302 - Acute Toxicity (Oral) Category 4 2020/1567 [1] Legend: 1. Classified by Chemwatch; 2. Classification drawn from GB-CLP Regulation, UK SI 2019/720 and UK SI 2020/1567